Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 19075187)


A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia.

Chen X, Bai F, Sokol L, Zhou J, Ren A, Painter JS, Liu J, Sallman DA, Chen YA, Yoder JA, Djeu JY, Loughran TP, Epling-Burnette PK, Wei S.

Blood. 2009 Apr 2;113(14):3226-34. doi: 10.1182/blood-2008-07-168245. Epub 2008 Dec 15.


Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.

Karimi M, Cao TM, Baker JA, Verneris MR, Soares L, Negrin RS.

J Immunol. 2005 Dec 15;175(12):7819-28.


DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells.

Wu J, Cherwinski H, Spies T, Phillips JH, Lanier LL.

J Exp Med. 2000 Oct 2;192(7):1059-68.


Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.

Jiang K, Zhong B, Gilvary DL, Corliss BC, Vivier E, Hong-Geller E, Wei S, Djeu JY.

J Immunol. 2002 Apr 1;168(7):3155-64.


Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.

Graham DB, Cella M, Giurisato E, Fujikawa K, Miletic AV, Kloeppel T, Brim K, Takai T, Shaw AS, Colonna M, Swat W.

J Immunol. 2006 Aug 15;177(4):2349-55.


Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms.

Snyder MR, Nakajima T, Leibson PJ, Weyand CM, Goronzy JJ.

J Immunol. 2004 Sep 15;173(6):3725-31.


Cloning, sequencing, and cell surface expression pattern of bovine immunoreceptor NKG2D and adaptor molecules DAP10 and DAP12.

Fikri Y, Nyabenda J, Content J, Huygen K.

Immunogenetics. 2007 Aug;59(8):653-9. Epub 2007 May 26.


Developing an in vitro model of T cell type of large granular lymphocyte leukemia.

Ren T, Yang J, Broeg K, Liu X, Loughran TP Jr, Cheng H.

Leuk Res. 2013 Dec;37(12):1737-43. doi: 10.1016/j.leukres.2013.10.002. Epub 2013 Oct 14.


DAP10- and DAP12-associated receptors in innate immunity.

Lanier LL.

Immunol Rev. 2009 Jan;227(1):150-60. doi: 10.1111/j.1600-065X.2008.00720.x. Review.


Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.

Verneris MR, Karimi M, Baker J, Jayaswal A, Negrin RS.

Blood. 2004 Apr 15;103(8):3065-72. Epub 2003 Nov 20. Erratum in: Blood. 2015 Apr 16;125(16):2583. Karami, Mobin [corrected to Karimi, Mobin].


NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells.

Upshaw JL, Arneson LN, Schoon RA, Dick CJ, Billadeau DD, Leibson PJ.

Nat Immunol. 2006 May;7(5):524-32. Epub 2006 Apr 2.


IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.

Burgess SJ, Marusina AI, Pathmanathan I, Borrego F, Coligan JE.

J Immunol. 2006 Feb 1;176(3):1490-7.


DAP10 contributes to CD8(+) T cell-mediated cytotoxic effector mechanisms during Mycobacterium tuberculosis infection.

Hessmann M, Rausch A, Rückerl D, Adams PS, Simon M, Gilfillan S, Colonna M, Ehlers S, Hölscher C.

Immunobiology. 2011 May;216(5):639-47. doi: 10.1016/j.imbio.2010.09.010. Epub 2010 Sep 24.


NKG2D splice variants: a reexamination of adaptor molecule associations.

Rabinovich B, Li J, Wolfson M, Lawrence W, Beers C, Chalupny J, Hurren R, Greenfield B, Miller R, Cosman D.

Immunogenetics. 2006 Apr;58(2-3):81-8. Epub 2006 Feb 10.


Rat and mouse CD94 associate directly with the activating transmembrane adaptor proteins DAP12 and DAP10 and activate NK cell cytotoxicity.

Saether PC, Hoelsbrekken SE, Fossum S, Dissen E.

J Immunol. 2011 Dec 15;187(12):6365-73. doi: 10.4049/jimmunol.1102345. Epub 2011 Nov 14.


Pathways participating in activation of mouse uterine natural killer cells during pregnancy.

Xie X, He H, Colonna M, Seya T, Takai T, Croy BA.

Biol Reprod. 2005 Sep;73(3):510-8. Epub 2005 May 4.


NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.

Gilfillan S, Ho EL, Cella M, Yokoyama WM, Colonna M.

Nat Immunol. 2002 Dec;3(12):1150-5. Epub 2002 Nov 11.


Activating NK-cell receptors co-stimulate CD4(+)CD28(-) T cells in patients with rheumatoid arthritis.

Fasth AE, Björkström NK, Anthoni M, Malmberg KJ, Malmström V.

Eur J Immunol. 2010 Feb;40(2):378-87. doi: 10.1002/eji.200939399.


T cells gene-engineered with DAP12 mediate effector function in an NKG2D-dependent and major histocompatibility complex-independent manner.

Teng MW, Kershaw MH, Hayakawa Y, Cerutti L, Jane SM, Darcy PK, Smyth MJ.

J Biol Chem. 2005 Nov 18;280(46):38235-41. Epub 2005 Sep 16.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk